[Bevacizumab (Avastin) related surgical complications: comment to Abbrederis K et al. (2007)]

Chirurg. 2008 Apr;79(4):356-60. doi: 10.1007/s00104-007-1340-6.

[Article in German]

Authors

F Lordick¹, J R Siewert

Affiliation

¹ Chirurgische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, München, Germany. f.lordick@lrz.tum.de

PMID: 17453166
DOI: 10.1007/s00104-007-1340-6

No abstract available

Publication types

Comment

MeSH terms

Anastomosis, Surgical*
Angiogenesis Inhibitors / adverse effects*
Angiogenesis Inhibitors / therapeutic use
Antibodies, Monoclonal / administration & dosage
Antibodies, Monoclonal / adverse effects*
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bevacizumab
Child, Preschool
Colectomy*
Diagnosis, Differential
Female
Humans
Ileum / blood supply*
Ileum / pathology
Ileum / surgery*
Intestinal Perforation / chemically induced*
Intestinal Perforation / diagnosis
Intestinal Perforation / pathology
Intestinal Perforation / surgery
Ischemia / chemically induced*
Ischemia / diagnosis
Ischemia / pathology
Ischemia / surgery
Middle Aged
Postoperative Hemorrhage / etiology
Risk Factors
Surgical Wound Dehiscence / chemically induced*
Surgical Wound Dehiscence / diagnosis
Surgical Wound Dehiscence / pathology
Surgical Wound Dehiscence / surgery
Wound Healing / drug effects

Substances

Angiogenesis Inhibitors
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Bevacizumab